Paper28343171
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays.
Palladini G and 16 others. Clin Chem Lab Med, 2017. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. Papers, record 28343171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28343171
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloidosis | Major topic |
| Immunoassay | Major topic |
| Immunoglobulin Light Chains | Major topic |
| Aged | |
| Antibodies, Monoclonal | |
| Female | |
| Humans | |
| Immunoglobulin Light-chain Amyloidosis | |
| Latex | |
| Male | |
| Middle Aged | |
| Nephelometry and Turbidimetry | |
| Prognosis |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959044 | Consistency and correlation of a domestic Kehua serum free light chain assay with two imported analytical systems. | Front Oncol | 2026 | https://conductscience.org/library/papers/42959044 | PubMed |
| 41705764 | Reply: Refining Free Light Chain Ratio in Systemic Amyloidosis. | JACC CardioOncol | 2026 | https://conductscience.org/library/papers/41705764 | PubMed |
| 41096780 | Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096780 | PubMed |
| 40967951 | Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40967951 | PubMed |
| 40938239 | Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis. | JACC CardioOncol | 2025 | https://conductscience.org/library/papers/40938239 | PubMed |
| 38745673 | Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis. | Front Immunol | 2024 | https://conductscience.org/library/papers/38745673 | PubMed |
| 38444090 | Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study. | ESC Heart Fail | 2024 | https://conductscience.org/library/papers/38444090 | PubMed |
| 36652193 | Diagnosis and Treatment of AL Amyloidosis. | Drugs | 2023 | https://conductscience.org/library/papers/36652193 | PubMed |
| 36103008 | A method to obtain purified free light chain monomers and dimers from urine samples of patients with multiple myeloma. | Immunol Res | 2022 | https://conductscience.org/library/papers/36103008 | PubMed |
| 36051065 | Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis. | EJHaem | 2022 | https://conductscience.org/library/papers/36051065 | PubMed |
| 35325395 | Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. | Intern Emerg Med | 2022 | https://conductscience.org/library/papers/35325395 | PubMed |
| 34393594 | Comparison of Freelite and N-Latex serum free light chain assays: a critical review. | Biochem Med (Zagreb) | 2021 | https://conductscience.org/library/papers/34393594 | PubMed |
| 33993188 | Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021. | Blood Cancer J | 2021 | https://conductscience.org/library/papers/33993188 | PubMed |
| 33457060 | Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach. | J Adv Pract Oncol | 2019 | https://conductscience.org/library/papers/33457060 | PubMed |
| 32885146 | Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management. | Hemasphere | 2020 | https://conductscience.org/library/papers/32885146 | PubMed |
| 32373710 | Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist. | Int J Cardiol Heart Vasc | 2020 | https://conductscience.org/library/papers/32373710 | PubMed |
| 31915365 | Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma. | Blood Cancer J | 2020 | https://conductscience.org/library/papers/31915365 | PubMed |
| 31049418 | Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease. | Health Sci Rep | 2019 | https://conductscience.org/library/papers/31049418 | PubMed |
| 30828116 | The Paraprotein - an Enduring Biomarker. | Clin Biochem Rev | 2019 | https://conductscience.org/library/papers/30828116 | PubMed |
| 29795248 | Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. | Blood Cancer J | 2018 | https://conductscience.org/library/papers/29795248 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28343171
GET https://conductscience.org/api/papers/v1/28343171/cited_by?page=2